Related Experiment Video
Updated: Dec 18, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic Chambers
Lucas Armbrecht1, Ophélie Rutschmann1, Barbara Maria Szczerba2
1Department for Biosystems Science and Engineering Bioanalytics Group ETH Zurich Mattenstrasse 26 Basel CH-4058 Switzerland.
This study introduces a microfluidic platform for capturing and analyzing circulating tumor cells (CTCs). The method efficiently isolates CTCs and quantifies secreted proteins, offering new insights into cancer progression.
Area of Science:
- Biomedical Engineering
- Oncology
- Microfluidics
Background:
- Circulating tumor cells (CTCs) are crucial for cancer metastasis and monitoring treatment efficacy.
- Current methods for CTC analysis are limited in providing detailed phenotypic and functional information.
- Understanding CTC secretion profiles can offer valuable insights into tumor behavior.
Purpose of the Study:
- To develop and validate a microfluidic platform for integrated capture, isolation, and analysis of CTCs.
- To enable quantification of secreted proteins from single CTCs and CTC clusters.
- To advance the functional profiling of CTCs for improved cancer diagnostics.
Main Methods:
- A microfluidic device with dedicated trapping structures for high-efficiency CTC capture (>95%).
- Integration of functionalized magnetic beads for co-capture and assessment of protein secretion.
- Application of bead-based assays for quantifying secreted proteins, including granulocyte growth stimulating factor (G-CSF).
- Testing with breast cancer cell lines and mouse-model-derived CTCs.
Main Results:
- Demonstrated high-efficiency isolation of CTCs from whole blood.
- Successfully quantified protein secretion from single CTCs and CTC clusters.
- Achieved a limit of detection of 1.5 ng mL⁻¹ for secreted proteins.
- Identified G-CSF secretion, linking it to neutrophil recruitment.
Conclusions:
- The developed microfluidic platform enables comprehensive functional profiling of CTCs.
- This technology enhances the ability to analyze CTC phenotypes and secreted factors.
- The platform holds potential for multiplexed analysis and future clinical applications in cancer management.
More Related Videos
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019